
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Undisclosed
Recipient : Kytopen
Deal Size : Undisclosed
Deal Type : Partnership
Details : Kytopen and Mirus Bio will collaborate to combine industry-leading technologies and tackle the non-viral delivery of highly complex genome engineering materials to help create human cellular medicines.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 31, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Undisclosed
Recipient : Kytopen
Deal Size : Undisclosed
Deal Type : Partnership
